Healthcare ❯ Pharmaceuticals ❯ Biopharmaceuticals

Generic Drugs

Teva Pharmaceutical Industries Limited Rinvoq

BMO Raises AbbVie Target to $240 After Rinvoq Generic Dispute Is Resolved

The call signals conviction in AbbVie’s growth drivers despite uncertainty over when generic Rinvoq will reach the U.S. market.

Teva Wins FDA Fast Track for Emrusolmin in Multiple System Atrophy